Patents by Inventor Michael P. Kane

Michael P. Kane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-[.omega.-(Dimethylamino)alkyl]-3',4'-dichloropropionanilides
    Patent number: 4286106
    Abstract: The present invention relates to novel organic compounds, useful as antidepressant agents. Further provided are novel methods for the preparation of these compounds and pharmaceutical compositions and methods of use. Particular compounds comprising an aspect of the present invention are N-[.omega.-(dimethylamino)alkyl]-3',4'-dichloropropionanilides.
    Type: Grant
    Filed: July 30, 1979
    Date of Patent: August 25, 1981
    Assignee: The Upjohn Company
    Inventors: Michael P. Kane, Jacob Szmuszkovicz
  • Anti-depressant N-(3,4-dichlorophenyl)-N-dimethylaminoalkylene amides
    Patent number: 4186208
    Abstract: A pharmaceutical formulation containing, as active ingredient, a compound of the Formula III: ##STR1## wherein A is a group selected from --(CH.sub.2).sub.2 --; --(CH.sub.2).sub.3 --; --(CH.sub.2).sub.4 --; --(CH.sub.2).sub.5 --; ##STR2## wherein R is ethyl, vinyl, or cyclopropyl; and wherein X is bromo or chloro, or the pharmacologically acceptable acid addition salts for the treatment of depression in warm-blooded animals, including man.
    Type: Grant
    Filed: January 29, 1979
    Date of Patent: January 29, 1980
    Assignee: The Upjohn Company
    Inventors: Michael P. Kane, Jacob Szmuszkovicz
  • N-(2-Dimethylaminoalkyl)-3',4'-dichloroanilides
    Patent number: 4180522
    Abstract: The present specification provides compounds of the formula: ##STR1## wherein A is a group selected from --(CH.sub.2).sub.2 --; --(CH.sub.2).sub.3 --; --(CH.sub.2).sub.4 --; ##STR2## wherein R is ethyl, vinyl, or cyclopropyl; and wherein X is bromo or chloro. These compounds, including the pharmacologically acceptable salts thereof, are disclosed as useful antidepressant agents in warm-blooded animals, particularly man.
    Type: Grant
    Filed: August 16, 1978
    Date of Patent: December 25, 1979
    Assignee: The Upjohn Company
    Inventors: Michael P. Kane, Jacob Szmuszkovicz